Contravisory Investment Management, Inc. Pfizer Inc Transaction History

Contravisory Investment Management, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 13, 2023	BUY	$41.75 - $54.5 $50,434 - $65,836	1,208 Added 17.74%	8,017 $0
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $3,719 - $4,540	85 Added 1.26%	6,809 $298,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $17,774 - $21,074	382 Added 6.02%	6,724 $353,000
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $290,146 - $359,527	6,342 New	6,342 $328,000
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $46,779 - $52,522	-1,265 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$37.5 - $41.2 $4,200 - $4,614	112 Added 9.71%	1,265 $54,000
Q4 2018 Jan 14, 2019	BUY	$38.47 - $43.86 $28,660 - $32,675	745 Added 182.6%	1,153 $50,000
Q3 2018 Oct 11, 2018	SELL	$34.47 - $41.81 $20,750 - $25,169	-602 Reduced 59.6%	408 $18,000
Q1 2018 Apr 09, 2018	BUY	$31.91 - $37.02 $319 - $370	10 Added 1.0%	1,010 $36,000
Q4 2017 Jan 18, 2018	SELL	$33.26 - $35.29 $4,290 - $4,552	-129 Reduced 11.43%	1,000 $36,000
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $34,999 - $38,555	1,129	1,129 $40,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.